Friday, March 1, 2013

LAWSUITS OVER AMERICAN MEDICAL SYSTEMS “ELEVATE” PELVIC ORGAN PROLAPSE MESH KIT "DEFLATES" ENDO HEALTH SOLUTIONS TO THE TUNE OF $640 MILLION – NOW WE ARE TALKING!!!

PRAISE GOD LINDA AND JEFF GROSS WON $11.1 MILLION VS ETHICON AND JOHNSON & JOHNSON…..WHAT SHE REALLY DESERVES IS HER LIFE BACK AND THE $11.1 MILLION, TOO!

BUT THE SOUND OF $640 MILLION DOLLARS OF PROFIT BEING SUCKED OUT OF ONE OF THESE DISGUSTING MESH COMPANIES IS REAL, REAL MUSIC TO MY EARS!!!

NO APPEAL. NO DEFENSE ATTORNEYS “BEGGING” THE JURY FOR MERCY. JUST $640 MILLION DOLLARS DOWN THE DRAIN FOR THE HORRIFIC PAIN AND AGONY THEY HAVE CAUSED TO THOUSANDS AND THOUSANDS OF WOMEN

HALLELUJAH!!!!!

Guess Dr. G. Willy Davila may be looking for new consulting positions to supplement his income at the Cleveland Clinic. His ‘leadership” and “ground breaking work in women’s pelvic health” is over.

Dr. G. Willy Davila operated on me for 7 years but never removed enough of the mesh out of my bladder to stop the pain. Dr. G. Willy Davila caused me immense ongoing pain by allowing the Ethicon Gynecare TVT Prolene polypropylene bladder mesh sling to keep sawing its way back into my bladder time, after time, after time following those awful in-office trimmings or surgeries in the hospital.

Nor did he bother to mention in deposition testimony or in his testimony at trial in my medical malpractice lawsuit against Dr. Bernard Cantor and Mt Sinai Medical Center in Miami Beach that he was a mesh consultant for American Medical Systems. Would have been nice for the jury to know he was not representing who he REALLY was.

Now maybe the insanity of mesh will end. Finally a blow big enough to get the attention of these greedy corporations that maybe, just maybe, mesh IS NOT A GOOD IDEA.

Years and years and years of my life have been dedicated to stopping the use of mesh FOR ANY REASON…HERNIA, BLADDER SUSPENSION OR PELVIC ORGAN PROLAPSE.

AT MEDIATION WITH ATTORNEY JEFFREY SHAPIRO, ARNSTEIN & LEHR LLP IN MIAMI AND THE ETHICON REPRESENTATIVE IN THE SUMMER OF 2007, I ASK FOR $7 MILLION DOLLARS FOR THE HARM CAUSED TO ME BY THEIR GYNECARE TVT SLING. I WAS OFFERED $5,000.00. I SAID “NO”!!

YOU KNOW, I THINK THAT WOULD HAVE BEEN THE CHEAPEST $7 MILLION J&J, ETHICON, GYNECARE EVER SPENT CAUSE I HAVE BEEN RAISING A RUCKUS EVER SINCE!

BUT THEN, IT WOULD HAVE KEPT ME FROM BEING A VOICE FOR ALL THE MEN AND WOMEN WHO DON’T HAVE ONE AND WHO ARE SO INJURED THEY CAN’T EVEN GET OUT OF BED!

PRAISE GOD!! THE WALLS ARE CRUMBLING!!

BELOW IS CUT & PASTE FROM PHILADELPHIA BUSINESS JOURNAL….

Endo Reports Fourth Quarter Financial Results And Reaffirms 2013 Financial Guidance

PR Newswire MALVERN, Pa., Feb. 28, 2013 /PRNewswire/ --

"- Total quarterly revenues of $801 million, comparable to prior year.

- Fourth quarter reported diluted (GAAP) loss per share of $6.35 includes a $640 million non-cash asset impairment charge related primarily to goodwill- Fourth quarter adjusted diluted EPS of $1.62 increased by 16 percent versus prior year; Full year 2012 adjusted diluted EPS of $5.02 was in-line with financial guidance.

- Company continues to expect 2013 revenues in the range of $2.80 billion to $2.95 billion.

- Company continues to expect 2013 adjusted diluted EPS in the range of $4.40 to $4.70;

- Company expects reported diluted (GAAP) EPS in the range of $2.22 to $2.52.

Endo Health Solutions (Nasdaq: ENDP) today reported total revenues during the fourth quarter of 2012 of $801 million, relatively flat when compared to $803 million in the same quarter of 2011. Endo incurred a net reported loss for the three months ended Dec 31, 2012 of $716 million, compared with reported net income of $37 million reported in the comparable 2011 period.

The net loss reported for the period includes the effect of a non-cash charge in the amount of $714 million for the period to reflect the impairment of certain assets. The primary driver for this charge is a $640 million reduction in  other intangible assets attributable to the company's AMS segment.
The net reported loss reported for the period also includes a charge in the amount of $232 million for the period reflecting the impact of accruals for legal and other contingencies. ...The remainder of this charge reflects a $92 million reserve for product liability claims."READ THE WHOLE ARTICLE AT...
http://www.bizjournals.com/philadelphia/prnewswire/press_releases/Pennsylvania/2013/02/28/PH68717

1 comment:

Anonymous said...

This Mesh is and was a big mistake.